Skip to main content
Erschienen in: Clinical Research in Cardiology 5/2015

01.05.2015 | Original Paper

Safety and efficacy of external electrical cardioversion in patients with left ventricular leads

verfasst von: Jakob Lüker, Georg von Bodman, Arian Sultan, Jürgen Brömsen, Ruken Ö. Akbulak, Benjamin Schäffer, Doreen Schreiber, Boris A. Hoffmann, Michael Block, Stephan Willems, Daniel Steven

Erschienen in: Clinical Research in Cardiology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Atrial arrhythmias lower the biventricular pacing percentage in cardiac resynchronization therapy (CRT) treated patients (pts) and have a high prevalence in this population. External electrical cardioversion (ECV) is commonly performed to restore sinus rhythm. There is a paucity of data on the safety and efficacy of ECV in pts with CRT devices.

Methods

Forty-three pts with CRT devices undergoing ECV at two centers were included prospectively. Devices were interrogated immediately prior to and after ECV, as well as after 4 weeks.

Results

Devices (CRT-D in 38 and CRT-P in 5) were all implanted in left pectoral position, with predominantly bipolar left ventricular (LV) leads. Sixty-one shocks were delivered, all biphasic. Arrhythmia had recurred in 36 % of pts at follow-up (FU). There was a significant increase in LV lead threshold voltage and drop in bipolar LV lead impedance after ECV, which returned to normal at FU. An at least twofold increase in pacing threshold voltage at FU was seen in 2 LV leads and a 0.5 V increase in threshold in 3 LV leads. Overall, biventricular pacing significantly increased during FU.

Conclusion

ECV in CRT pts was safe and effective in this two-center study. A transient increase in LV lead pacing threshold was observed. Relevant changes in pacing threshold at FU occurred in five LV leads—identification and regular FU of these pts are necessary. Restoring SR through ECV significantly increased the biventricular pacing percentage but arrhythmia recurrence was frequent. CRT pts with atrial arrhythmias require close FU after ECV.
Literatur
1.
Zurück zum Zitat Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338CrossRefPubMed Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338CrossRefPubMed
2.
Zurück zum Zitat Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395CrossRefPubMed Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395CrossRefPubMed
3.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed
4.
Zurück zum Zitat Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360CrossRefPubMed Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360CrossRefPubMed
5.
Zurück zum Zitat Hayes DL, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475CrossRefPubMed Hayes DL, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475CrossRefPubMed
6.
Zurück zum Zitat Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32,844 patients. Circ Arrhythm Electrophysiol 5:884–888CrossRefPubMed Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32,844 patients. Circ Arrhythm Electrophysiol 5:884–888CrossRefPubMed
7.
Zurück zum Zitat Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ (2014) The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter–defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 63:1190–1197CrossRefPubMed Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ (2014) The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter–defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 63:1190–1197CrossRefPubMed
8.
Zurück zum Zitat Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL (2014) The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 7:370–376CrossRefPubMed Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL (2014) The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 7:370–376CrossRefPubMed
9.
Zurück zum Zitat Lown B, Neuman J, Amarasingham R, Berkovits BV (1962) Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 10:223–233CrossRefPubMed Lown B, Neuman J, Amarasingham R, Berkovits BV (1962) Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 10:223–233CrossRefPubMed
10.
Zurück zum Zitat Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33(21):2719–2747CrossRefPubMed Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33(21):2719–2747CrossRefPubMed
11.
Zurück zum Zitat January CT, Wann LS, Alpert JS, et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation January CT, Wann LS, Alpert JS, et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation
12.
Zurück zum Zitat Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed
13.
Zurück zum Zitat Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed
14.
Zurück zum Zitat Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed
15.
Zurück zum Zitat Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter–defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter–defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed
16.
Zurück zum Zitat Tracy CM, Akhtar M, DiMarco JP, Heart Rhythm Society et al (2006) American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517CrossRefPubMed Tracy CM, Akhtar M, DiMarco JP, Heart Rhythm Society et al (2006) American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517CrossRefPubMed
17.
Zurück zum Zitat Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef
18.
Zurück zum Zitat Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275–1279CrossRefPubMed Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275–1279CrossRefPubMed
19.
Zurück zum Zitat Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677CrossRefPubMed Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677CrossRefPubMed
20.
Zurück zum Zitat Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894–1903CrossRefPubMed Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894–1903CrossRefPubMed
21.
Zurück zum Zitat Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726CrossRefPubMed Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726CrossRefPubMed
Metadaten
Titel
Safety and efficacy of external electrical cardioversion in patients with left ventricular leads
verfasst von
Jakob Lüker
Georg von Bodman
Arian Sultan
Jürgen Brömsen
Ruken Ö. Akbulak
Benjamin Schäffer
Doreen Schreiber
Boris A. Hoffmann
Michael Block
Stephan Willems
Daniel Steven
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 5/2015
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-014-0800-5

Weitere Artikel der Ausgabe 5/2015

Clinical Research in Cardiology 5/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.